Sofinnova Investments, Inc. - BLUEPRINT MEDICINES CORP ownership

BLUEPRINT MEDICINES CORP's ticker is BPMC and the CUSIP is 09627Y109. A total of 288 filers reported holding BLUEPRINT MEDICINES CORP in Q3 2021. The put-call ratio across all filers is 0.49 and the average weighting 0.2%.

Quarter-by-quarter ownership
Sofinnova Investments, Inc. ownership history of BLUEPRINT MEDICINES CORP
ValueSharesWeighting
Q4 2021$26,261,000
+40.5%
245,182
+34.8%
1.53%
+38.6%
Q3 2021$18,697,000
+152.6%
181,860
+91.7%
1.11%
+137.0%
Q2 2020$7,401,000
+100.6%
94,891
+50.4%
0.47%
+37.0%
Q1 2020$3,690,000
-35.9%
63,100
-12.2%
0.34%
-38.6%
Q1 2019$5,753,000
+43.5%
71,866
+40.0%
0.56%
+55.5%
Q3 2018$4,008,000
-37.9%
51,339
-49.5%
0.36%
-13.3%
Q2 2018$6,456,000101,6990.41%
Other shareholders
BLUEPRINT MEDICINES CORP shareholders Q3 2021
NameSharesValueWeighting ↓
Aquilo Capital Management, LLC 716,539$36,192,00012.35%
CADIAN CAPITAL MANAGEMENT, LP 2,020,629$102,062,0006.89%
Casdin Capital, LLC 1,150,000$58,087,0004.91%
DAFNA Capital Management LLC 261,280$13,197,0003.60%
Nextech Invest Ltd. 188,228$9,507,0003.21%
Eagle Health Investments LP 170,551$8,615,0002.01%
Boxer Capital, LLC 507,374$25,627,0001.62%
Rock Springs Capital Management LP 979,174$49,458,0001.44%
EFG Asset Management (North America) Corp. 130,454$6,589,0001.39%
Integral Health Asset Management, LLC 130,000$6,566,0001.35%
View complete list of BLUEPRINT MEDICINES CORP shareholders